Loading…
Based on limited metadata, A.P. Deauville, LLC received an FDA Warning Letter on November 8, 2019, regarding drug products under their purview. Without access to the full letter text or detailed subject information, the specific nature of the violations cannot be determined from the available metadata. The warning falls under FDA's drug product regulatory authority, though the specific issuing office is not documented in this metadata summary.